SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-012253
Filing Date
2022-03-29
Accepted
2022-03-29 17:24:15
Documents
14
Period of Report
2022-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtvt-8k_20220329.htm   iXBRL 8-K 28952
2 EX-99.1 vtvt-ex991_6.htm EX-99.1 502440
3 GRAPHIC g0p5gfeguyq0000001.jpg GRAPHIC 13695
  Complete submission text file 0001564590-22-012253.txt   703949

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20220329.xsd EX-101.SCH 5705
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20220329_lab.xml EX-101.LAB 19431
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20220329_pre.xml EX-101.PRE 11591
8 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-8k_20220329_htm.xml XML 3563
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 22782125
SIC: 2834 Pharmaceutical Preparations